Eli Lilly's COVID-19 treatment now authorized high-risk patients 'of any age' [MarketWatch]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MarketWatch
Authorization (EUA) for its bamlanivimab and etesevimab, taken together, to treat certain high-risk patients that are under the age of 12, even newborns. "With the FDA's decision to allow use of bamlanivimab with etesevimab in children and infants, Lilly can now offer treatment and prevention options to high-risk individuals of any age," said Daniel Skovronsky, Lilly's chief scientific and medical officer. Lilly said bamlanivimab and etesevimab taken together retains neutralization activity against the delta variant of the coronavirus that causes COVID-19, and the drug maker is working to understand neutralization activity on the omicron variant. Lilly's stock, which fell 1.9% in afternoon trading Friday, has rallied 44.0% year to date, while the S&P 500 SPX, has gained 19.7%.
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk comes under Senate probe over pricing for weight loss drugs [Seeking Alpha]Seeking Alpha
- Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- 4 Large Drug Stocks to Hold on to Amid Industry Challenges [Yahoo! Finance]Yahoo! Finance
- Wegovy Access Expands to Millions in US on Medicare, Study Finds [BNN Bloomberg (Canada)]BNN Bloomberg
- Biogen Profit Beats Street Estimates as Cost-Cutting Takes Hold [BNN Bloomberg (Canada)]BNN Bloomberg
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website